Extension Study to Assess Effects of Non-interrupted Versus Interrupted and Long Term Treatment of Two Dose Regimes of Secukinumab in Subjects With Hidradenitis Suppurativa
Public ClinicalTrials.gov record NCT04179175. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-blind, Randomized Withdrawal Extension Study of Subcutaneous Secukinumab to Demonstrate Long-term Efficacy, Safety and Tolerability in Subjects With Moderate to Severe Hidradenitis Suppurativa
Study identification
- NCT ID
- NCT04179175
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 703 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 17, 2020
- Primary completion
- May 25, 2023
- Completion
- Jul 14, 2026
- Last update posted
- Mar 10, 2026
2020 – 2026
United States locations
- U.S. sites
- 29
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northwest Arkansas Center | Rogers | Arkansas | 72758 | — |
| MedDerm Associates | San Diego | California | 92103 | — |
| University Clinical Trials | San Diego | California | 92123 | — |
| Southern California Skin and Laser | Whittier | California | 92677 | — |
| Florida Academic Centers Research and Education LLC | Coral Gables | Florida | 33134 | — |
| University of MiamiHealth System | Miami | Florida | 33125 | — |
| Olympian Clinical Research | Tampa | Florida | 33609 | — |
| University Of South Florida | Tampa | Florida | 33612 | — |
| Advanced Medical Research | Sandy Springs | Georgia | 30328 | — |
| Endeavor Health | Glenview | Illinois | 60077 | — |
| Dundee Dermatology | West Dundee | Illinois | 60118 | — |
| Dawes Fretzin Clinical Rea Group | Indianapolis | Indiana | 46256 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Beth Israel Deaconess Med Center | Boston | Massachusetts | 02215 | — |
| Minnesota Clinical Study Center | New Brighton | Minnesota | 55112 | — |
| MediSearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| St Louis U Clinical Trials | St Louis | Missouri | 63104 | — |
| WA Uni School Of Med | St Louis | Missouri | 63110 | — |
| Skin Specialists PC | Omaha | Nebraska | 68144 | — |
| Icahn School Of Med At Mount Sinai | New York | New York | 10029 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27516 | — |
| Wright State University | Fairborn | Ohio | 45324 | — |
| UP Medical Center H System | Pittsburgh | Pennsylvania | 15213-3403 | — |
| Clinical Research Ctr of Carolinas | Charleston | South Carolina | 29407 | — |
| Bellaire Dermatology Associates | Bellaire | Texas | 77401 | — |
| MDRI Baylor University | Dallas | Texas | 75246-1613 | — |
| Austin Inst for Clinical Research | Pflugerville | Texas | 78660 | — |
| Dr. Stephen Miller, MDPA | San Antonio | Texas | 78229 | — |
| Virginia Clinical Research | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 162 non-U.S. sites.
Recently updated Hidradenitis Suppurativa trials
Other public records listing Hidradenitis Suppurativa. Sorted by last update posted; newest first. Not a recommendation.
- NCT07665437: An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS Recruiting
- NCT05507125: Regulation of Inflammatory Genes in Hidradenitis Suppurativa Recruiting
- NCT06468228: A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Active, not recruiting
- NCT06840392: A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa Active, not recruiting
- NCT06326476: Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa. Recruiting
- NCT06799000: A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1) Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04179175, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 10, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04179175 live on ClinicalTrials.gov.